Australia's most trusted
source of pharma news
Friday, 20 February 2026
Posted 20 February 2026 AM
More than 40 novel drugs secured their first approval in 2025, with four of those brands reaching Australia.
Clarivate compiled a list of ‘novel treatments that shaped the 2025 regulatory landscape’ in its recently released Drugs to Watch 2026 report. These drugs won their first approval last year (as of 16 December) in Australia, Canada, the EU, Japan, Mainland China, the UK, or the US.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.